Magaña RMC, Hurtado MVS, Fernández MRF, Arenas R

Language: Spanish
References: 15
Page: 8-12
PDF size: 188.07 Kb.

ABSTRACT

Introduction: Cellular immunity in recipients of kidney transplants is often compromised due to long-term use of immunosuppressants, leading to a higher risk of skin infections by dermatophytes, yeasts or opportunistic fungi.
Objective: To establish the prevalence of superficial mycoses in kidney transplant recipients from our hospital.
Materials and methods: For this descriptive, observational, prospective and cross-sectional study, 51 specimens suggestive of superficial mycoses were subject to KOH analysis and fungal culture.
Results: The sample included 94 kidney transplant recipients (54 men, 57.4%; 40 women, 42.6%. Age average: 32.85 years) with superficial mycosis documented in 34 patients (prevalence: 36%). Observed infections included: toenail onychomycosis (24 cases; 70.5%), tinea pedis (5 cases: 3 plantar, 2 interdigital; 14.6%), tinea corporis (2 cases; 5.8%), fingernail onychomycosis (2 cases; 5.8%) and tinea faciei (1 case; 2.9%). Candida albicans was isolated in 8 fungal cultures.
Discussion: Our findings correlate with existing reports, with Candida albicans as the most frequent pathogen.

REFERENCES

1. Belloni Fortina A, Piaserico S, Alaibac M, Caforio ALP, Brandolisio L, Zacchello G, Franco Zanon G, Zancan L, Peserico A. “Desórdenes cutáneos en pacientes trasplantados en la infancia”. Transplant International 2005; 8(3): 360-365.

2. Giachetti A, Carbajosa A, Hidalgo Parra I, Galimberti G, Galimberti R. “Manifestaciones cutáneas de infecciones micóticas en pacientes trasplantados pediátricos”. Piel 2005; 20(4): 183-189.

3. Singh N, Heitman J. “Antifungal attributes of immunosuppressive agents: new paradigms in management and elucidating the pathophysiologic basis of opportunistic mycoses in organ transplant recipients”. Transplant 2004; 77: 795-800.

4. Blohme I, Larko O. “Skin lesions in renal transplant patients after 10-23 years of immunosuppressive therapy”. Acta Derm Venereol 1990; 70: 491-494.

5. Rugeles MJ, Vásquez JL, Jaramillo E, Orozco B, et al. “Etiología y características clínicas de las onicomicosis en un grupo de pacientes inmunosuprimidos”. Infectio 2001; 5(1): 7-13.

6. Bowden RA, Ljungman P, Paya CV. “Skin Infections after hematopoietic stem cells or solid organ transplant”. En: Transplant Infections, 3ª ed., Philadelphia, USA, Lippincott Williams & Wilkins 2010: 203-213.

7. Singh N, Gayowski T, Wagener MM, et al. “Invasive fungal infections in liver transplant recipients receiving tacrolimus as the primary immunosuppressive agent”. Clin Infect Dis 1997; 24: 179-184.

8. Sentamil G, Kamalan A, Ajithados C, et al. “Clinical and mycological features of dermatophytosis in renal transplant recipients”. Mycoses 1999; 42: 75-78.

9. Gulec AT, Demirbilek M, Seckin D, et al. “Superficial fungal infections in 102 renal transplant recipients: a case control study”. J Am Acad Dermatol 2003; 49: 187-92.

10. Coll L, Pellerano G, Brunet R, et al. “Estudio de observación de lesiones dermatológicas en trasplantados renales”. Arch Arg Dermatol 1996; 46: 257-266.

11. Virgili A, Zampino MR, La Malfa V, et al. “Prevalence of superficial dermatomycoses in 73 renal transplant recipients”. Dermatology 1999; 199: 31-34.

12. González Ramos M, Ferraris JR, Galimberti RL. “Alteraciones dermatológicas en pacientes pediátricos con trasplantes renales”. Arch Arg Dermatol 1989; 39: 156-167.

13. Patterson TF. “Approaches to fungal diagnosis in transplantation”. Transpl Infect Dis 1999; 4: 262-272.

14. Wingard JR, Leather H. “A new era of antifungal therapy”. Biol Blood Marrow Transplant 2004; 10: 73-90.

15. Weinberg JM, Koestenblatt E, Tutrone WD, Tishler H R, Najarian L. “Comparación de los métodos diagnósticos en la evaluación de onicomicosis”. J Am Acad Dermatol 2003; 49: 193-197.